Pages that link to "Q37467533"

The following pages link to Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production (Q37467533):

Displaying 43 items.

• Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation (Q23912498) (← links)
• Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis (Q26795604) (← links)
• Nitric oxide synthase derangements and hypertension in kidney disease (Q26849234) (← links)
• Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables (Q26865426) (← links)
• Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1 (Q27665385) (← links)
• Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine (Q28506246) (← links)
• Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. (Q30493459) (← links)
• Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine (Q33816492) (← links)
• Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. (Q33904265) (← links)
• A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1 (Q34020342) (← links)
• Discovery of Halopyridines as Quiescent Affinity Labels: Inactivation of Dimethylarginine Dimethylaminohydrolase (Q34572283) (← links)
• Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt (Q34721519) (← links)
• Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanoma. (Q35031641) (← links)
• Genotyping on ALDH2: comparison of four different technologies (Q35214357) (← links)
• Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism (Q35315250) (← links)
• Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension. (Q35933350) (← links)
• Cellular interactions between L-arginine and asymmetric dimethylarginine: Transport and metabolism (Q36386405) (← links)
• Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats (Q36820553) (← links)
• Demethylation treatment restores erectile function in a rat model of hyperhomocysteinemia (Q37210355) (← links)
• Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia. (Q37297962) (← links)
• Molecular mechanisms underlying the activation of eNOS. (Q37655580) (← links)
• The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. (Q37860140) (← links)
• Appropriate Protein and Specific Amino Acid Delivery Can Improve Patient Outcome: Fact or Fantasy? (Q37878985) (← links)
• Nitric oxide: a guardian for vascular grafts? (Q37887771) (← links)
• A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. (Q38652256) (← links)
• Arginine Metabolism Revisited. (Q39033964) (← links)
• Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis (Q41870668) (← links)
• DDAH: a target for vascular therapy? (Q42716627) (← links)
• DDAH says NO to ADMA (Q42791219) (← links)
• Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension (Q42907431) (← links)
• Metabolomic profiles indicate distinct physiological pathways affected by two loci with major divergent effect on Bos taurus growth and lipid deposition (Q42963654) (← links)
• Ammonia reduces intracellular ADMA level in cultured astrocytes and endothelial cells: possible involvement of increased y+LAT2-mediated efflux. (Q46198263) (← links)
• Asymmetric dimethylarginine levels in children with β-thalassemia and their correlations to tricuspid regurgitant jet velocity (Q46789974) (← links)
• Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction (Q46972648) (← links)
• Dimethylarginine-dimethylaminohydrolase-2 (DDAH-2) does not metabolize methylarginines (Q48308299) (← links)
• Effect of dietary restriction and subsequent re-alimentation on the transcriptional profile of bovine jejunal epithelium. (Q52648796) (← links)
• Mesenteric vascular remodeling in hyperhomocysteinemia (Q54401846) (← links)
• Forskolin attenuates doxorubicin-induced accumulation of asymmetric dimethylarginine and s-adenosylhomocysteine via methyltransferase activity in leukemic monocytes. (Q54985792) (← links)
• A Pilot Study to Assess Kidney Functions and Toxic Dimethyl-arginines as Risk Biomarkers in Women with Low Vitamin D Levels (Q64071281) (← links)
• DDAH1 regulates apoptosis and angiogenesis in human fetal pulmonary microvascular endothelial cells. (Q64890496) (← links)
• Asymmetric Dimethylarginine Levels in Buerger’s Disease (Q83721256) (← links)
• Obeticholic acid, a Farensoid-X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats (Q87430870) (← links)
• The Second Life of Methylarginines as Cardiovascular Targets (Q90163907) (← links)